疫情准备的DNA疫苗:SARS-CoV-2和之后
Joel N Maslow1,2, Ijoo Kwon1, Sagar B Kudchodkar1
1GeneOne Life Science, Inc., Seoul 04500, Republic of Korea.
Vaccines
|June 28, 2023
概括
DNA疫苗显示出对SARS-CoV-2的快速生产,稳定性和安全性优势. 基因德尔姆设备非常适合全球运动,将DNA疫苗定位为有前途的未来流行病解决方案.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- SARS-CoV-2 流行病加速了疫苗的开发.
- 与传统的疫苗平台相比,DNA疫苗提供了潜在的优势.
研究的目的:
- 审查在SARS-CoV-2的DNA疫苗,这些疫苗已经达到第2阶段或以上.
- 根据用户需求和成本效益,比较临床试验中使用的设备.
主要方法:
- 对DNA疫苗候选人的综合文献审查.
- 基于用户要求和经济因素的输送设备的比较分析.
主要成果:
- 几种DNA疫苗已进入临床试验阶段,其中一些已获得授权.
- 基因德尔姆吸收装置在大规模疫苗接种工作中显示出显著的好处.
结论:
- DNA 疫苗是一个有希望的,可快速生产的,稳定的疫情准备方案.
- 基因德尔姆装置提高了国际DNA疫苗部署的可行性.
更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.6K
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.6K
相关概念视频
Vaccinations
44.8K
Overview
44.8K
Cross-reactivity
31.3K
Overview
31.3K
Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
